Nature Communications (May 2021)
Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy
Abstract
Proteolysis targeting chimeras (PROTACs) is an effective alternative to modulate protein homeostasis but can lead to uncontrollable protein degradation and off-target side effects. Here, the authors developed semiconducting polymer nano-PROTACs with phototherapeutic and activatable protein degradation abilities for photo-immunometabolic cancer therapy.